Exelixis, Inc. (EXEL)
44.49
-0.32
(-0.71%)
USD |
NASDAQ |
Jan 22, 16:00
44.49
0.00 (0.00%)
After-Hours: 18:05
Exelixis Total Assets (Annual): 2.987B for Dec. 31, 2024
Total Assets (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Annual) Benchmarks
| Vanda Pharmaceuticals, Inc. | 656.20M |
| ADMA Biologics, Inc. | 498.38M |
| Aldeyra Therapeutics, Inc. | 104.61M |
| Natera, Inc. | 1.686B |
| Merck & Co., Inc. | 117.11B |